Quantrx Biomedical Corp (QTXB)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 13, 16:00
Quantrx Biomedical Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2019 | 0.2006M |
June 30, 2019 | 0.2006M |
March 31, 2019 | 0.2006M |
December 31, 2018 | 0.2006M |
September 30, 2018 | 0.4969M |
June 30, 2018 | 0.4969M |
March 31, 2018 | 0.4969M |
December 31, 2017 | 0.4969M |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | -0.05M |
March 31, 2016 | -0.05M |
December 31, 2015 | -0.05M |
September 30, 2015 | -0.02M |
June 30, 2015 | 0.06M |
March 31, 2015 | 0.09M |
December 31, 2014 | 0.12M |
September 30, 2014 | 0.12M |
June 30, 2014 | 0.12M |
March 31, 2014 | 0.11M |
December 31, 2013 | 0.08M |
September 30, 2013 | 0.05M |
Date | Value |
---|---|
June 30, 2013 | 0.02M |
March 31, 2013 | 0.00 |
December 31, 2012 | -0.0055M |
September 30, 2012 | -0.0055M |
June 30, 2012 | -0.0055M |
March 31, 2012 | -0.0055M |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.916M |
June 30, 2011 | 0.916M |
March 31, 2011 | 1.438M |
December 31, 2010 | 1.688M |
September 30, 2010 | 0.7715M |
June 30, 2010 | 0.6186M |
March 31, 2010 | 0.0471M |
December 31, 2009 | -0.2917M |
September 30, 2009 | -0.4146M |
June 30, 2009 | -0.2921M |
March 31, 2009 | -0.2421M |
December 31, 2008 | -0.1783M |
September 30, 2008 | 0.0776M |
June 30, 2008 | 0.0686M |
March 31, 2008 | -0.1663M |
December 31, 2007 | -0.9873M |
September 30, 2007 | -1.639M |
June 30, 2007 | -2.056M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
0.2006M
Minimum
Sep 2019
0.2006M
Maximum
Sep 2019
0.2006M
Average
0.2006M
Median
Sep 2019
Cash from Investing (TTM) Benchmarks
Medite Cancer Diagnostics Inc | -0.106M |
SheerVision Inc | -- |
Sunridge International Inc | -- |
Perspective Therapeutics Inc | -50.91M |
Xtant Medical Holdings Inc | -8.123M |